SCHOTT Pharma AG & Co. KGaA (SHTPY)
OTCMKTS · Delayed Price · Currency is USD
4.370
-0.130 (-2.89%)
At close: Jan 2, 2026
SHTPY Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 240.19M EUR in the quarter ending December 31, 2025, with 4.50% growth. This brings the company's revenue in the last twelve months to 995.03M, up 4.23% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.
Revenue (ttm)
995.03M EUR
Revenue Growth
+4.23%
P/S Ratio
2.39
Revenue / Employee
206.82K EUR
Employees
4,811
Market Cap
2.79B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
SCHOTT Pharma AG & Co. KGaA News
- 2 months ago - SCHOTT Pharma AG & Co. KGaA (SHTPY) Q4 2025 Earnings Call Transcript - Seeking Alpha